# 95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

> **NCT05631028** · NA · COMPLETED · sponsor: **Shiyou Wei** · enrollment: 115 (actual)

## Conditions studied

- Lung Cancer
- Anesthesia Induction

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Remimazolam tosilate

## Key facts

- **NCT ID:** NCT05631028
- **Lead sponsor:** Shiyou Wei
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-01-01
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05631028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05631028, "95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05631028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*